Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196):企業の財務・戦略的SWOT分析

◆英語タイトル:Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH138889FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism and digestive system, cardiovascular system, blood system, central nervous system drugs, anti-infection, anti-tumor, vaccine and raw material and intermediates. Fosun Pharma provides medical diagnostic products such as real time PCR detector, human papillomavirus assay kit, HBV quantitative reagent, and biofosun microorganism identification and susceptibility analysis system. The company’s research and development unit concentrates on therapeutic areas of metabolism and digestive system, blood system, cardiovascular system and central nervous system. Fosun Pharma is headquartered in Shanghai, China.

Shanghai Fosun Pharmaceutical (Group) Co Ltd Key Recent Developments

Mar 29,2021: Fosun Pharma Announces 2020 Annual Results
Nov 12,2020: Shanghai Fosun Pharmaceutical : Overseas regulatory announcement
Oct 30,2020: Fosun Pharma announces 2020 third quarterly report innovative drug development entered intensive harvest period and performance continued steady growth
Oct 29,2020: Shanghai Fosun Pharmaceutical : Change of chairman and authorised representative re-designation of directors and adjustment of senior management
Aug 26,2020: Fosun Pharma announces 2020 interim results

This comprehensive SWOT profile of Shanghai Fosun Pharmaceutical (Group) Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Shanghai Fosun Pharmaceutical (Group) Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Information
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Overview
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Employees
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Employee Biographies
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Operational Heads
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Major Products and Services
Shanghai Fosun Pharmaceutical (Group) Co Ltd – History
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Company Statement
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Locations And Subsidiaries
Shanghai Fosun Pharmaceutical (Group) Co Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Shanghai Fosun Pharmaceutical (Group) Co Ltd – Business Description
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Corporate Strategy
Shanghai Fosun Pharmaceutical (Group) Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Strengths
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Weaknesses
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Opportunities
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Threats
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Shanghai Fosun Pharmaceutical (Group) Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Information
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Ratios
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Share Data
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Major Products and Services
Shanghai Fosun Pharmaceutical (Group) Co Ltd, History
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Employees
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Employee Biographies
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Operational Heads
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Other Locations
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Subsidiaries
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Competitors
Shanghai Fosun Pharmaceutical (Group) Co Ltd, SWOT Analysis
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Ratios based on current share price
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Annual Ratios
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Polaris Infrastructure Inc (PIF):企業の財務・戦略的SWOT分析
    Summary Polaris Infrastructure Inc (Polaris Infrastructure), formerly Ram Power Corp is a renewable energy company that explores, acquires, operates and develops geothermal energy projects in Latin America. The company owns and operates San Jacinto Tizate Geothermal project, which is located in nort …
  • Companhia Paranaense de Energia SA (CPLE6):企業の財務・戦略的SWOT分析
    Companhia Paranaense de Energia SA (CPLE6) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • InviCRO LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary InviCRO LLC (InviCRO) a subsidiary of Konica Minolta Inc, is a provider of image informatics, engineering and operational services in translational drug discovery and development. The company developed VivoQuant, a DICOM compliant post-processing suite for image data combining fundamental vi …
  • Daido Steel Co., Ltd.:企業の戦略・SWOT・財務分析
    Daido Steel Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daido Steel Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Nexter Group:企業の戦略・SWOT・財務情報
    Nexter Group - Strategy, SWOT and Corporate Finance Report Summary Nexter Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Akzo Nobel N.V.:企業の戦略・SWOT・財務情報
    Akzo Nobel N.V. - Strategy, SWOT and Corporate Finance Report Summary Akzo Nobel N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Bauer AG (B5A):企業の財務・戦略的SWOT分析
    Bauer AG (B5A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • SELEX Galileo Inc.:企業の戦略・SWOT・財務情報
    SELEX Galileo Inc. - Strategy, SWOT and Corporate Finance Report Summary SELEX Galileo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cambrex Corp (CBM):企業の財務・戦略的SWOT分析
    Summary Cambrex Corp (Cambrex) is a life science company that focuses on the development and commercialization of small molecule therapeutics. The company’s major products include active pharmaceutical ingredients (APIs), advanced intermediates and drug delivery products for branded and generic phar …
  • Montefiore Medical Center-製薬・医療分野:企業M&A・提携分析
    Summary Montefiore Medical Center (MMC) is a healthcare service provider that offers clinical services. The center offers services such as allergy and immunology, orthopaedics, dentistry and oral surgery, dermatology, endocrinology, digestive and liver diseases, neurological surgery, otorhinolaryngo …
  • CellScope Inc:製品パイプライン分析
    Summary CellScope Inc (CellScope) is a medical device company that offers smart mobile tools to facilitate easy access to health answers. The company offers Oto, a smart tool that attaches with mobile and take a video of the inside of ear; Seymour, an in-app guidance and phone attachments help to ca …
  • Ormat Technologies Inc (ORA):企業の財務・戦略的SWOT分析
    Ormat Technologies Inc (ORA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Five Star Senior Living Inc (FVE):企業の財務・戦略的SWOT分析
    Summary Five Star Senior Living Inc (Five Star), formerly Five Star Quality Care Inc is a healthcare service provider that offers senior living and patient care services. The center’s services include independent living, assisted living, skilled nursing care, memory care, dining and nutrition, hospi …
  • Svenska Petroleum Exploration AB:石油・ガス:M&Aディール及び事業提携情報
    Summary Svenska Petroleum Exploration AB (Svenska Petroleum), a subsidiary of Petroswede AB is an oil and gas company that offers offshore oil exploration and production. The company operates 3D Sendji data and acquisition of new 3D data in Kaba area to explore for the pre-salt. It has oil and gas p …
  • Austrian Airlines AG:企業の戦略・SWOT・財務情報
    Austrian Airlines AG - Strategy, SWOT and Corporate Finance Report Summary Austrian Airlines AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • MModal IP LLC:企業の戦略的SWOT分析
    MModal IP LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Glycotope GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Glycotope GmbH (Glycotope) is a biopharmaceutical company that develops immuno-oncology products for the treatment of various types of cancer. The company’s expression platform offers proprietary technologies such as Glycobody (GET) and GlycoExpress(GEX) that allows the glycosylation of anti …
  • UNIQA Serbia:企業の戦略・SWOT・財務情報
    UNIQA Serbia - Strategy, SWOT and Corporate Finance Report Summary UNIQA Serbia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Grupo Elektra, S.A. de C.V.:企業の戦略・SWOT・財務分析
    Grupo Elektra, S.A. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Grupo Elektra, S.A. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Ohr Pharmaceutical Inc (OHRP):製薬・医療:M&Aディール及び事業提携情報
    Summary Ohr Pharmaceutical Inc (Ohr), formerly BBM Holdings Inc, is a pharmaceutical company that develops novel therapies for ophthalmic diseases. The company offers products such as squalamine lactate ophthalmic solution and SKS sustained release technology products. Its squalamine lactate ophthal …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆